AlphaMaven AlphaMaven

Repeat Entrepreneurs Raise $22 Million for Health-AI Startup Aevius

Reported by WSJ
Nov 19, 2026· 1 min read
Save Post LinkedIn Email
Key Takeaways
  • • Aevius, a health-AI startup, has raised $22 million, according to the Wall Street Journal's reporting on the round.
  • • The founding team previously built Modella AI, which drugmaker AstraZeneca acquired in January 2026.
  • • Aevius aims to use AI to help healthcare providers, life sciences companies and health insurers make better use of their data.
  • • The company represents a broader ambition for the team than Modella's cancer-focused biomedical work.
Summary
Repeat entrepreneurs have raised $22 million for Aevius, a health-AI startup, the Wall Street Journal reported. The round was highlighted in the publication's startup newsletter, which noted that the company's founders previously built Modella AI.

Modella AI was a cancer-focused biomedical startup that drugmaker AstraZeneca acquired in January. According to the WSJ, the team behind Modella is now back with a new company and a broader mandate. Aevius seeks to apply artificial intelligence to help healthcare providers, life sciences companies and health insurers better use the data they hold.

The primary source is a brief newsletter item and does not disclose the investors in the round, valuation, or detailed product plans. Readers seeking further detail on the financing terms or the company's commercial roadmap should consult the full WSJ report.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

WSJ Repeat Entrepreneurs Raise $22 Million for Health-AI Startup Aevius